IMVT
Immunovant, Inc.Healthcare$24.50
▲ Bullish
Mkt Cap: $4.99B|Float: 77.5M|SI: 21.4%|DTC: 15.9
Data as of market close Apr 2, 2026
IV Rank
70
IV Pctl
56%
HV 20d
4696.0%
52W Range
$13-$29
ATR(14)
$1.27
Exp. Move
±11.1%
P/C Ratio
0.16
Earnings
May 28
GEX Positive
DEX Long
Net Call Premium
IV High
Max Pain Below
Exp. Move Wide
Low Put/Call
IMVT Key Options Data
- IV Rank
- 69.6%
- Total GEX
- $0.00B
- Total DEX
- $1.3M
- Max Pain
- $22.00
- Expected Move
- ±11.1%
- Put/Call OI
- 0.16
- Net Premium
- $0.1M
- Spot Price
- $24.50
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$2.72 | ±11.1% | $21.77 | $27.23 |
| 2026-05-15 | 43 | ±$2.60 | ±10.6% | $21.90 | $27.10 |
| 2026-06-18 | 77 | ±$9.92 | ±40.5% | $14.58 | $34.42 |
| 2026-07-17 | 106 | ±$12.50 | ±51.0% | $12.00 | $37.00 |
| 2026-08-21 | 141 | ±$11.85 | ±48.4% | $12.65 | $36.35 |
| 2026-09-18 | 169 | ±$7.10 | ±29.0% | $17.40 | $31.60 |
Explore IMVT options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.